Roche & Quest Establish Toeholds in Emerging Alzheimer’s Blood Testing Market
While Roche has an early lead, Quest recently made key moves to improve its position in the AD patient-initiated blood testing market.
Keeps You Up-to-Date on Lab Business and Competitive Strategy, Market Trends and Opportunities, and M&A and Investment Activity in Today’s Diagnostic Lab Industry
While Roche has an early lead, Quest recently made key moves to improve its position in the AD patient-initiated blood testing market.
An overview of likely lab audit targets for the coming year, and how laboratories can ensure they’re prepared.
How laboratories can avoid compliance issues involving certain marketing and staffing practices.
Healthcare leader Steve Serota discusses a new partnership and how it is bringing high-quality lab testing to underserved areas.
Missing small details or getting them wrong can be disastrous for a lab move—here’s how to avoid major issues.
As is usual at this time of year, deals in the diagnostics industry were up, both in terms of volume and value.
What lab leaders need to know about the FDA’s three new 510(k) draft guidances.
This month’s roundup of cases includes Walgreens’ settlement with Theranos customers, kickbacks, and age discrimination.
The compliance risks of giving referral sources software or equipment to ensure the security of protected health information.
This template aims to help lab leaders develop a policy for donations of cybersecurity technology that complies with safe harbor requirements.
Lab leaders say that the increased level of scrutiny proposed for such tests would be a detriment to innovation and patient care.